Join us on 16th - 17th June online to master the art of crafting Standard Operating Procedures (SOPs) within regulated environments.
More information
RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More information21st May 2026
Summary:
The UK government has announced landmark plans to accelerate the development and availability of treatments for rare diseases, aiming to reduce delays for patients with limited therapeutic options. The proposals include more flexible regulatory approaches, closer collaboration with industry and researchers, and improved support for innovation in areas such as gene and cell therapies. By streamlining processes and encouraging earlier engagement with developers, the initiative seeks to make the UK a more attractive environment for cutting edge research while ensuring high standards of safety and effectiveness. The plans are part of a broader effort to strengthen the life sciences sector and deliver faster access to life changing treatments for patients.